1. Home
  2. DRTS vs OPK Comparison

DRTS vs OPK Comparison

Compare DRTS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$12.68

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.36

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
OPK
Founded
2015
2006
Country
Israel
United States
Employees
121
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
978.2M
1.1B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
DRTS
OPK
Price
$12.68
$1.36
Analyst Decision
Strong Buy
Hold
Analyst Count
3
3
Target Price
$8.67
$1.60
AVG Volume (30 Days)
812.0K
2.9M
Earning Date
05-18-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$606,879,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$699.98
$4.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.87
$0.98
52 Week High
$14.11
$1.61

Technical Indicators

Market Signals
Indicator
DRTS
OPK
Relative Strength Index (RSI) 63.84 38.88
Support Level $6.59 $1.25
Resistance Level N/A $1.41
Average True Range (ATR) 0.86 0.07
MACD 0.15 -0.02
Stochastic Oscillator 70.26 0.00

Price Performance

Historical Comparison
DRTS
OPK

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Share on Social Networks: